{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:29:53Z","timestamp":1790281793046,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014337","name":"Furthermore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Martin and Toni Sosnoff Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.exer.2020.108209","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T21:06:01Z","timestamp":1601586361000},"page":"108209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease"],"prefix":"10.1016","volume":"201","author":[{"given":"Y.","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Asbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.exer.2020.108209_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00417-002-0477-8","article-title":"Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis sicca","volume":"240","author":"Aho","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108209_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.dib.2016.11.027","article-title":"Dataset of tear film cytokine levels in dry eye disease (DED) patients with and without HIV infection","volume":"10","author":"Balne","year":"2017","journal-title":"Data Brief"},{"issue":"32","key":"10.1016\/j.exer.2020.108209_bib3","doi-asserted-by":"crossref","first-page":"29799","DOI":"10.1074\/jbc.M211763200","article-title":"Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation","volume":"278","author":"Beck","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.exer.2020.108209_bib4","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.165.5.2790","article-title":"Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes","volume":"165","author":"Bidgood","year":"2000","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.exer.2020.108209_bib5","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1167\/iovs.11-7266","article-title":"Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays","volume":"52","author":"Boehm","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.exer.2020.108209_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/emmm.201000072","article-title":"A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis","volume":"2","author":"Boilard","year":"2010","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.exer.2020.108209_bib7","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1074\/jbc.M110.123927","article-title":"A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism","volume":"286","author":"Bryant","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.exer.2020.108209_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7827(01)00002-9","article-title":"Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis","volume":"40","author":"Capper","year":"2001","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.exer.2020.108209_bib9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.exer.2008.11.035","article-title":"sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised","volume":"88","author":"Chen","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.exer.2020.108209_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mi.2013.20","article-title":"Chronic dry eye disease is principally mediated by effector memory Th17 cells","volume":"7","author":"Chen","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"7","key":"10.1016\/j.exer.2020.108209_bib11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/1573406413666170209121317","article-title":"A concise update on the relevance of secretory phospholipase A2 group IIA and its inhibitors with cancer","volume":"13","author":"Chen","year":"2017","journal-title":"Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.exer.2020.108209_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1388-1981(00)00109-8","article-title":"Structure, function, and regulation of group V phospholipase A(2)","volume":"1488","author":"Cho","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.exer.2020.108209_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"issue":"6 Suppl. l","key":"10.1016\/j.exer.2020.108209_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-27492008000700017","article-title":"Rationale for anti-inflammatory therapy in dry eye syndrome","volume":"71","author":"de Paiva","year":"2008","journal-title":"Arq. Bras. Oftalmol."},{"issue":"18","key":"10.1016\/j.exer.2020.108209_bib15","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","article-title":"Diversity of group types, regulation, and function of phospholipase A2","volume":"269","author":"Dennis","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.exer.2020.108209_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop","volume":"5","author":"Dews","year":"2007","journal-title":"Ocul. Surf."},{"issue":"2","key":"10.1016\/j.exer.2020.108209_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1006\/bbrc.2000.3468","article-title":"Internalization and degradation of type IIA phospholipase A(2) in mast cells","volume":"276","author":"Enomoto","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2020.108209_bib18","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"Enriquez-de-Salamanca","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2020.108209_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.exer.2013.03.018","article-title":"HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease","volume":"111","author":"Epstein","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108209_bib20","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.2741\/2998","article-title":"The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine","volume":"13","author":"Fijneman","year":"2008","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.exer.2020.108209_bib21","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1167\/iovs.02-0851","article-title":"Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines","volume":"44","author":"Gipson","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.exer.2020.108209_bib22","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1167\/iovs.11-9054","article-title":"Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease","volume":"53","author":"Huang","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.exer.2020.108209_bib23","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1167\/iovs.16-19757","article-title":"Tear interferon-gamma as a biomarker for evaporative dry eye disease","volume":"57","author":"Jackson","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2020.108209_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":"Tear cytokine profiles in dysfunctional tear syndrome","volume":"147","author":"Lam","year":"2009","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2020.108209_bib25","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J."},{"issue":"4","key":"10.1016\/j.exer.2020.108209_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173301","article-title":"Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease","volume":"12","author":"Liu","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.108209_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajo.2015.09.039","article-title":"Clinical and molecular inflammatory response in sjogren syndrome-associated dry eye patients under desiccating stress","volume":"161","author":"Lopez-Miguel","year":"2016","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2020.108209_bib28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of inflammatory cytokines in the tears of dry eye patients","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.exer.2020.108209_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12886-017-0646-5","article-title":"Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye","volume":"17","author":"McDonnell","year":"2017","journal-title":"BMC Ophthalmol."},{"issue":"2\u20133","key":"10.1016\/j.exer.2020.108209_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbalip.2005.01.001","article-title":"Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells","volume":"1733","author":"Menschikowski","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.exer.2020.108209_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2005.10.005","article-title":"Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?","volume":"79","author":"Menschikowski","year":"2006","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"2","key":"10.1016\/j.exer.2020.108209_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.advms.2017.03.003","article-title":"Pro-inflammatory cytokines associated with clinical severity of dry eye disease of patients with depression","volume":"62","author":"Mrugacz","year":"2017","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.exer.2020.108209_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.ai.2016.05.001","article-title":"The roles of the secreted phospholipase A2 gene family in immunology","volume":"132","author":"Murakami","year":"2016","journal-title":"Adv. Immunol."},{"issue":"2","key":"10.1016\/j.exer.2020.108209_bib34","first-page":"417","article-title":"Secretion of group 2 phospholipase A2 by lacrimal glands","volume":"35","author":"Nevalainen","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"22","key":"10.1016\/j.exer.2020.108209_bib35","doi-asserted-by":"crossref","first-page":"23357","DOI":"10.1074\/jbc.M309283200","article-title":"Eotaxin-3\/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role","volume":"279","author":"Petkovic","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.exer.2020.108209_bib36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","article-title":"The diagnosis and management of dry eye: a twenty-five-year review","volume":"19","author":"Pflugfelder","year":"2000","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.exer.2020.108209_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jtos.2018.05.001","article-title":"Severity, therapeutic, and activity tear biomarkers in dry eye disease: an analysis from a phase III clinical trial","volume":"16","author":"Pinto-Fraga","year":"2018","journal-title":"Ocul. Surf."},{"issue":"6","key":"10.1016\/j.exer.2020.108209_bib38","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1128\/IAI.66.6.2791-2797.1998","article-title":"Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears","volume":"66","author":"Qu","year":"1998","journal-title":"Infect. Immun."},{"issue":"23","key":"10.1016\/j.exer.2020.108209_bib39","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/MCB.00623-07","article-title":"Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6","volume":"27","author":"Ravaux","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.exer.2020.108209_bib40","doi-asserted-by":"crossref","first-page":"2532314","DOI":"10.1155\/2018\/2532314","article-title":"Innate and adaptive cell populations driving inflammation in dry eye disease","volume":"2018","author":"Reyes","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.exer.2020.108209_bib41","first-page":"318","article-title":"Group II PLA(2) content of tears in normal subjects","volume":"42","author":"Saari","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"38","key":"10.1016\/j.exer.2020.108209_bib42","doi-asserted-by":"crossref","first-page":"26107","DOI":"10.1074\/jbc.M804835200","article-title":"Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner","volume":"283","author":"Saegusa","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.exer.2020.108209_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08830185.2012.748052","article-title":"Dry eye as a mucosal autoimmune disease","volume":"32","author":"Stern","year":"2013","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.exer.2020.108209_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2020.108209_bib45","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1167\/iovs.06-0293","article-title":"Establishment of a cultivated human conjunctival epithelium as an alternative tissue source for autologous corneal epithelial transplantation","volume":"47","author":"Tanioka","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2020.108209_bib46","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.4049\/jimmunol.170.6.3279","article-title":"Secretory phospholipases A2 activate selective functions in human eosinophils","volume":"170","author":"Triggiani","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.exer.2020.108209_bib47","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jaci.2005.08.011","article-title":"Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes","volume":"116","author":"Triggiani","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.exer.2020.108209_bib48","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.06-0998","article-title":"Comparative analysis of human conjunctival and corneal epithelial gene expression with oligonucleotide microarrays","volume":"48","author":"Turner","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2020.108209_bib49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.preteyeres.2012.05.003","article-title":"Ocular surface inflammation is regulated by innate immunity","volume":"31","author":"Ueta","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2020.108209_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","article-title":"The core mechanism of dry eye disease is inflammation","volume":"40","author":"Wei","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"7","key":"10.1016\/j.exer.2020.108209_bib51","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1167\/iovs.10-6350","article-title":"sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB\/c mouse model","volume":"52","author":"Wei","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2020.108209_bib52","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1167\/iovs.11-8684","article-title":"Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands","volume":"53","author":"Wei","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"13","key":"10.1016\/j.exer.2020.108209_bib53","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1167\/iovs.13-12132","article-title":"Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures","volume":"54","author":"Wei","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"14","key":"10.1016\/j.exer.2020.108209_bib54","doi-asserted-by":"crossref","first-page":"DES192","DOI":"10.1167\/iovs.17-23651","article-title":"Inflammatory response in dry eye","volume":"59","author":"Yamaguchi","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2020.108209_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","article-title":"Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.exer.2020.108209_bib56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1167\/iovs.09-3425","article-title":"Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome","volume":"51","author":"Yoon","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352030467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352030467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:30:54Z","timestamp":1762147854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448352030467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":56,"alternative-id":["S001448352030467X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108209","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108209"}}